|
Volumn 31, Issue 3, 1999, Pages 1649-1653
|
Bioequivalence criteria for cyclosporine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
DIGOXIN;
GENERIC DRUG;
PHENYTOIN;
AREA UNDER THE CURVE;
BIOEQUIVALENCE;
CONFERENCE PAPER;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
ETHNIC DIFFERENCE;
HUMAN;
MAXIMUM ALLOWABLE CONCENTRATION;
PRESCRIPTION;
PRIORITY JOURNAL;
ADULT;
AGE FACTORS;
CHEMISTRY, PHARMACEUTICAL;
CHILD;
CLINICAL TRIALS;
CONTINENTAL POPULATION GROUPS;
CYCLOSPORINE;
DRUGS, GENERIC;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
THERAPEUTIC EQUIVALENCY;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 0033135798
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(99)00085-8 Document Type: Conference Paper |
Times cited : (18)
|
References (60)
|